USPTO serial 99896554
NOVEXA HEALTH
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DAVIS, MARC STEPHEN
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with NOVEXA HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dallas, TX, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ZAKIR MIR
ZAKIR MIRBorderless Counsel, 8 The Green #24699Dover, DE 19901United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplements in the form of gummies for children, namely nutritional supplements to support bone growth and development, growth hormone support, sleep quality, immune function, and mineral absorption; Dietary supplements in the form of gummies for children, to support bone growth; Dietary supplements in the form of gummies for children to support bone development; Dietary supplements in the form of gummies for children for growth hormone support; Dietary supplements in the form of gummies for children to help improve sleep quality; Dietary supplements in the form of gummies for children to improve immune function; Dietary supplements in the form of gummies for children to improve mineral absorption; Dietary and nutritional supplements containing calcium, vitamin D3, vitamin K2, L-arginine, L-glutamine, ashwagandha, spirulina, and zinc; Dietary and nutritional supplements containing calcium; Dietary and nutritional supplements containing vitamin D3; Dietary and nutritional supplements containing vitamin K2; Dietary and nutritional supplements containing L-arginine; Dietary and nutritional supplements containing L-glutamine; Dietary and nutritional supplements containing ashwagandha; Dietary and nutritional supplements containing spirulina; Dietary and nutritional supplements containing zinc; Gummy vitamins; Dietary supplements for humans; Dietary and nutritional supplements for promoting healthy growth and development in children; Dietary and nutritional supplements for bone growth and development in children; Dietary and nutritional supplements for growth hormone support in children; Dietary and nutritional supplements for improving sleep quality for children; Dietary and nutritional supplements for improving immune function for children; Dietary and nutritional supplements for improving mineral absorption for children | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 25, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2026 | NWAP | NEW APPLICATION ENTERED | — |